Literature DB >> 10854697

Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the pro-alpha1(I) collagen gene expression by thyroid hormone receptor.

W J Chen1, K H Lin, Y S Lee.   

Abstract

The purpose of this study was to gain insights into the underlying mechanism of myocardial fibrosis during hypothyroidism. Treatment of cardiac fibroblasts with a medium lacking thyroid hormone led to a 47% increase in [3H]thymidine incorporation into the cell nuclei compared with that in untreated cells. Northern blot analysis of RNA from cardiac fibroblasts grown in a thyroid hormone depleted medium resulted in a 38% increase in the abundance of mRNA for pro-alpha1(I) collagen. At the protein level, the amount of type I collagen, as determined by immunoprecipitation, was increased either in the cell lysate (46%) of cardiac fibroblasts grown in a thyroid hormone depleted medium or in the medium (44%). The chimeric plasmid, ColCAT 3.6, contains the 5'-flanking region of the rat pro-alphal(I) collagen gene (from bases -3520 to +115) fused to the chloramphenicol acetyltransferase (CAT) gene. The plasmid was cotransfected with thyroid hormone receptor (TR) expression plasmid into rat cardiac fibroblasts and COS-l cells (monkey mesangial cells). Cells transfected with the ColCAT plasmid in the presence of thyroid hormone (100 nM T(3)) had a significant decrease (39% in fibroblasts, P<0.01; 52% in COS-1 cells, P<0.001) in CAT activity when compared to cells not exposed to thyroid hormone. Transient co-transfection of TR with various pro-alphal(I) collagen/CAT deletion constructs showed that T(3)-dependent repression was preserved with the deletion from 3520 bp of the flanking sequence to a 5' end point at position -224, indicating that a thyroid hormone-response element (TRE) was localized at the region -224 to +115. The TR-DNA binding assays demonstrated binding of the human TRbeta1 to a fragment containing a proposed TRE located between position -35 and +115 in the 5'-flanking region of the rat pro-alphal(I) collagen gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854697     DOI: 10.1016/s0303-7207(00)00203-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  20 in total

1.  Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats.

Authors:  Jianqiang Li; Zhaorui Liu; Hongwei Zhao; Fengxiang Yun; Zhaoguang Liang; Dingyu Wang; Xinbo Zhao; Jiawei Zhang; Hai Cang; Yilun Zou; Yue Li
Journal:  Endocrine       Date:  2019-06-07       Impact factor: 3.633

2.  Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.

Authors:  Kuo Zhang; Wenyao Wang; Shihua Zhao; Stuart D Katz; Giorgio Iervasi; A Martin Gerdes; Yi-Da Tang
Journal:  Clin Cardiol       Date:  2018-01-23       Impact factor: 2.882

3.  Editorial: Hypothyroidism and the Heart: Much More Than Meets the Eye.

Authors:  Ajay K Sharma; Sachin Shah; Sarju Ganatra; G Muqtada Chaudhry
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Oct-Dec

4.  Early and Short-term Triiodothyronine Supplementation Prevents Adverse Postischemic Cardiac Remodeling: Role of Transforming Growth Factor-β1 and Antifibrotic miRNA Signaling.

Authors:  Giuseppina Nicolini; Francesca Forini; Claudia Kusmic; Letizia Pitto; Laura Mariani; Giorgio Iervasi
Journal:  Mol Med       Date:  2015-11-23       Impact factor: 6.354

5.  The expression of mRNA of cytokines and of extracellular matrix proteins in triiodothyronine-treated rat hearts.

Authors:  Barbara Ziegelhöffer-Mihalovicová; Wilfried Briest; Hideo A Baba; Beate Rassler; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

Review 6.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

7.  Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription.

Authors:  Rosanne Rouf; Sarah Greytak; Eric C Wooten; Jing Wu; Jay Boltax; Michael Picard; Eric C Svensson; Wolfgang H Dillmann; Richard D Patten; Gordon S Huggins
Journal:  Circ Res       Date:  2008-07-25       Impact factor: 17.367

8.  Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats.

Authors:  Youhua Zhang; Eduard I Dedkov; Diana Teplitsky; Nathan Y Weltman; Christine J Pol; Viswanathan Rajagopalan; Bianca Lee; A Martin Gerdes
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-09-14

9.  Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.

Authors:  Youhua Zhang; Eduard I Dedkov; Bianca Lee; Ying Li; Khusbu Pun; A Martin Gerdes
Journal:  J Card Fail       Date:  2014-11-25       Impact factor: 5.712

10.  Effect of low thyroid function on cardiac structure and function in spontaneously hypertensive heart failure rats.

Authors:  Bassel Kisso; Ankit Patel; Rebecca Redetzke; A Martin Gerdes
Journal:  J Card Fail       Date:  2008-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.